![]() Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap SolutionMiami-based supplement pioneer combines enteric-coated dihydroberberine with a patent-pending (U.S. App. No. 63/837,080) P-gp efflux modulator, targeting the two documented barriers to berberine absorption that most supplements never address
By: RevGenetics "The question we kept asking was: why is the supplement industry selling a mechanism - AMPK activation - with a delivery system that undermines the mechanism?" said RevGenetics founder Anthony Loera. "Most every major brand in the berberine category is selling a standard vegetarian capsule with berberine. Nobody in the supplement industry was solving them in a single product." Unlike standard formulas, The DiBerberine 300x Triple-Action Protocol sets a new standard by combining:
Manufactured in the USA in a cGMP-certified, third-party tested facility, DiBerberine 300x is now available at revgenetics.com. A 30-day supply (30 enteric capsules) is priced at $44.95. Health and wellness influencers, practitioners, and marketers interested in partnering with RevGenetics for this launch can access the affiliate program at getlink.revgenetics.com. Media Contact RevGenetics news@revgenetics.com 305-929-3819 Photos: https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ End
|